AzTrials
AzTrials

VertigoSTANDING-MNCT06515951

Effectiveness of the STANDING Algorithm for the Differential Diagnosis of Vertigo

An observational study of Vertigo, run by Peiman Nazerian at 4 sites in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Differential diagnosis of vertigo is complex especially in emergency department, nevertheless it is crucial. The aim of this study is to assess the accuracy of STANDING algorithm for discriminate central from peripheral type of vertigo, identifying more easily the presence of ischemic stroke. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Vertigo
What is being tested?
STANDING algorithm
How many people
456 participants
Where
4 sitesItaly
Study dates
9 Jun 2022to 1 Nov 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Every adult patient presenting in emergency department with vertigo, dizziness or balance disorder.

Who may be able to join

  • patients over 18 years of age.
  • patients affected by vertigo, dizziness or balance disorder.

Who cannot join

  • age under 18.
  • patients unable to cooperate (with severe dementia or incapable to provide consensus).
  • patients affected by disease of cervical spine or any trauma of this part of body that contraindicate the manipulation of neck.
  • impractical follow-up.
  • dying patient (less three estimated months to live).
  • patients with neurologic deficit identified during triage examination (Cincinnati Prehospital stroke scale, CPSS>0) of suffering from another disease that can be the cause of dizziness/balance disorder (e.g. anemia, arrhythmia, hypoglycemia, alcoholic intoxication).
  • patients without symptoms at the time of examination.
  • patients who deny the participation in the study.

Trial locations and contacts

4 sites in 1 country.

Italy4 sites
  • Azienda USL Toscana Centro, Medicina d'Urgenza e Dipartimento Emergenza e Area Critica

    Empoli, Firenze, 50053

  • Azienda Ospedaliera Universitaria Careggi, Medicina d'Urgenza

    Florence, Tuscany, 50134

  • Nuovo Ospedale di Prato, Medicina d'Urgenza

    Prato, 59100

  • Ospedale Versilia, Medicina d'Urgenza

    Viareggio, Lucca, 55049

Other trials in Italy

About this study

Official title: Diagnostic Accuracy of the STANDING Algorithm for the Differential Diagnosis of Vertigo in the Emergency Department: a Multicenter Study.

Differential diagnosis of vertigo is complex especially in emergency department, nevertheless it is crucial. The aim of this study is to assess the accuracy of STANDING algorithm for discriminate central from peripheral type of vertigo, identifying more easily the presence of ischemic stroke.

Read the detailed description

Vertigo represents a common medical problem which afflicts about 20-30% of the population and it is a frequent cause of abstention from work and disability. In most cases it is provoked by a benign disease of inner ear, however it can be the main symptom of a more dangerous illness like ischemic or hemorragic stroke, cerebral neoplasm or demyelinating disease. Indeed, vertigo is the prevailing clinical problem in patients with misdiagnosed ischemic stroke, leading to an increase of mortality in the acute phase of disease. In the current state, two diagnostic algorithm have been proposed for the evaluation of acute vertigo, named with the acronyms HINTS and STANDING. The former is characterized by high sensibility and specificity when utilized by a specialist physician, but it is cumbersome to used in emergency department. Conversely, the latter has been validated exactly in this setting and comprises the evaluation of benign paroxysmal positional vertigo and of upright position. The aim of this study is to estimate the accuracy of STANDING algorithm in differentiating peripheral vertigo from central from, in particular ischemic stroke, and its potential usefulness in decreasing the use of neuroimaging and specialist consultant.

Conditions
Vertigo
Being tested
STANDING algorithm
Keywords
Central vertigo, Peripheral vertigo, Ischemic stroke
Medical subject headings
Vertigo, Ischemic Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • STANDING algorithmDiagnostic test

    The STANDING algorithm is composed by four steps. The first phase consists in evaluating the presence of spontaneous nystagmus at rest for at least five minutes with and without Frenzel goggles in order to assess if a acute vestibular syndrome is present. If there is not a spontaneous nystagmus, then positional maneuvers (Pagnini-Mc Cure and Dix-Hallpike) have to be performed. Otherwise if spontaneous nystagmus is observed, its feature are fundamental to diagnose a central vertigo. If nystagmus characteristics suggest a peripheral form, the head impulse test is performed by instructing the patient to keep eyes on a fixed target and then turned the head quickly. An abnormal response is typical of vestibular neuritis. In any cases after the described maneuvers, the patient must be evaluated when standing up and walking: if this turn out to be impossibile, the test is indicative of central nervous system disease.

Study groups in NCT06515951
Study groupRoleWhat they receive
STANDING groupConsecutive adult patients who access the emergency room due to vertigo / imbalance will be considered eligible for the study. in this group patients will be evaluated by STANDING protocol
Receives: Diagnostic Test: STANDING algorithm
Control groupConsecutive adult patients who access the emergency room due to vertigo / imbalance will be considered eligible for the study. in this group patients will be evaluated by standard of care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Accuracy of STANDING algorithm for the diagnosis of types of vertigo.

    Accuracy (proportion of true positive and negative cases among the total number of cases examined) together with sensitivity, specificity, negative and positive predictive values, negative and positive likelihood ratios of STANDING algorithm performed by emergency physicians to distinguish central and peripheral vertigo.

    Measured: Thirty days

Secondary outcomes (4)
  1. Change in the use of neuroimaging

    Evaluation if the use of STANDING algorithm can reduce the number neuroimaging (a composite of CT of the head and brain MRI) exams performed in patients with suspected central vertigo according to the STANDING algorithm.

    Measured: Thirty days

  2. Safety of hospital discharge

    Evaluation if the use of STANDING algorithm allows a safe discharge of patients with diagnosis of benign vertigo. At 1 month follow-up we evaluate the composite of: number of readmissions for stroke, need for cerebral revasculation procedures, for neurosurgery or all cause death or death for stroke) in patients without suspected central vertigo according to the STANDING algorithm.

    Measured: Thirty days

  3. Accuracy for diagnosis of stroke

    Accuracy (proportion of true positive and negative cases of stroke among the total number of cases examined)

    Measured: Thirty days

  4. Change in the use of specialist consultant

    Evaluation if the use of STANDING algorithm can reduce the number of specialist medical consultations (composite of neurological and ENT consultations) performed in patients with suspected central vertigo according to the STANDING algorithm.

    Measured: thirty days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jul 2024
  2. Study start9 Jun 2022
  3. Primary completion9 Jun 2023
  4. Study completion1 Nov 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
456 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06515951
Sponsor's protocol ID
11085
Acronym
STANDING-M
Status last verified
Jul 2024
First submitted
10 May 2023
Last updated
23 Jul 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Vertigo, run by Peiman Nazerian at 4 sites in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Accuracy of STANDING algorithm for the diagnosis of types of vertigo. (time frame: Thirty days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in